Pregabalin

Alternative Names: Lyrica

Pregabalin is an anticonvulsant and anxiolytic medication approved in some countries (like the UK and EU) for generalized anxiety disorder (GAD), though it is not FDA-approved for anxiety in the U.S. It works by modulating calcium channels in the nervous system, reducing the release of excitatory neurotransmitters, which helps calm overactive nerve signals associated with anxiety. It tends to work faster than SSRIs, often within a few days, and does not cause sexual dysfunction. Common side effects include dizziness, drowsiness, weight gain, and peripheral edema.

Treatment Type: Prescription Medication

Treatment Class: Other

Treatment Modality: Oral

Review Summary

3.0

1 Reviews

Preferred by 0 Reviewers

Based on the review, Pregabalin shows promise for treating anxiety, particularly in Europe where it is approved for generalized anxiety disorder. While not FDA-approved for anxiety in the U.S., it may be a beneficial off-label treatment, especially for patients who also experience neuropathic pain, offering a dual benefit with its quick onset.

This summary was generated by users' reviews

Breakdown by Category

Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.

Cost
5.0
1 = Very Expensive 5 = Very Affordable

5.0

Very Affordable
Relief Speed
2.0
1 = No Relief 5 = Immediate Relief

2.0

Slow Relief
Side Effects
3.0
1 = Intolerable Effect 5 = No Effect

3.0

Moderate Effect
Treatment Line
1.0
1 = Third-line or more 5 = First-line

1.0

Third-line or more

Explore various treatment options to empower yourself in making a well-informed choice.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

3.0

1 Reviews
5
0%
4
0%
3
100%
2
0%
1
0%

AI Summary of User Experiences

Not medical advice.

Based on the review, Pregabalin shows promise for treating anxiety, particularly in Europe where it is approved for generalized anxiety disorder. While not FDA-approved for anxiety in the U.S., it may be a beneficial off-label treatment, especially for patients who also experience neuropathic pain, offering a dual benefit with its quick onset.

Reviews

Filter by reviewer type Pro

Cost
Very Expensive
$1000+
Expensive
$501 to $1000
Moderate Cost
$101 to $500
Affordable
$25 to $100
Very Affordable
$25
Relief Speed
No Relief
No noticeable improvement
Slow Relief
Several days to weeks
Moderate Relief
Within 1 - 3 days
Fast Relief
Within hours
Immediate Relief
Within minutes
Side Effect
Intolerable Side Effect
Caused treatment to stop or required hospitalization
Severe Side Effect
Difficult to tolerate, may require intervention
Moderate Side Effect
Noticeable, but manageable
Mild Side Effect
Minor, not bothersome
No Side Effect
Without any adverse effects
Treatment Line
Third-line or more
Used after second-line failed or multiple prior treatment
Second-line
Used after first-line treatment failed or was unsuitable
First-line
First treatment tried
Dr. Curbside

Dr. Curbside

Verified
Physician • Emergency Medicine • How doctors think about decisions — and what real-world experiences add
2 months ago
Pregabalin can be a useful option for anxiety, especially when the symptoms are more physical—things like restlessness, muscle tension, or feeling constantly on edge. It often works faster than SSRIs, and some people notice improvement within a few days to a week. It’s approved for anxiety in some countries, but in the U.S. it’s not FDA-approved for anxiety and is usually used off-label. It can make more sense if someone also has a condition it is approved for, like neuropathic pain, fibromyalgia, or seizures. Side effects like dizziness, sedation, and weight gain can happen, so those are worth keeping in mind when considering it.
#VeryAffordable #SlowRelief #ModerateEffect #Third-lineOrMore #Maintenance